Home Hospital for Suddenly Ill Adults
NCT03524222 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3000
Last updated 2026-03-17
Summary
The investigators propose a home hospital model of care that substitutes for treatment in an acute care hospital. Limited studies of the home hospital model have demonstrated that a sizeable proportion of acute care can be delivered in the home with equal quality and safety, reduced cost, and improved patient experience.
Conditions
- Infection
- Heart Failure
- COPD
- Asthma
- Gout Flare
- Chronic Kidney Diseases
- Hypertensive Urgency
- Atrial Fibrillation Rapid
- Anticoagulants; Increased
Interventions
- OTHER
-
Home Hospitalization
See above
Sponsors & Collaborators
-
Brigham and Women's Hospital
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-01-18
- Primary Completion
- 2030-09-30
- Completion
- 2031-09-30
Countries
- United States
Study Locations
More Related Trials
-
Safety Surveillance of Targeted Drugs for Pulmonary Hypertension Using a Computerized Follow-up System: a Nationwide Cohort Study
NCT05372263 ·Status: RECRUITING
-
Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator Testing
NCT00626028 ·Status: COMPLETED ·Phase: PHASE3
-
Acute Exposure to High Altitude on Symptoms
NCT03593005 ·Status: COMPLETED ·Phase: NA
-
The Role of Endothelin in Pulmonary Hypertension
NCT00759408 ·Status: COMPLETED ·Phase: PHASE2
-
Acute Excposure of High Altitude on ECG and Non-invasive Blood Pressure.
NCT03593083 ·Status: COMPLETED ·Phase: NA
-
Acute Exposure of High Altitude on Cardiac Output
NCT03637218 ·Status: COMPLETED ·Phase: NA
-
HA Residents With PVD, Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) With and Without Supplemental Oxygen Therapy (SOT)
NCT06084559 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Medication Reconciliation in Pulmonary Hypertension
NCT04744584 ·Status: COMPLETED
-
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
NCT01728220 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Inhaled Albuterol in Pulmonary Hypertension
NCT03270332 ·Status: COMPLETED ·Phase: PHASE2
-
Bosentan for Severe Mitral Valve Dysfunction
NCT01270750 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Oxygen Treatment and Pulmonary Arterial Hypertension
NCT03683082 ·Status: UNKNOWN ·Phase: NA
-
A Trial to Determine the Relative Effect of PM101 I.V. Versus Placebo on Hemodynamics in Healthy Adult Volunteers
NCT00502346 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Therapy of Bosentan and Aerosolized Iloprost in Idiopathic Pulmonary Arterial Hypertension (IPAH)
NCT00120380 ·Status: TERMINATED ·Phase: PHASE4
-
Acute Exposure of Simulated Hypoxia on ECG and Non-invasive Blood Pressure
NCT03581851 ·Status: COMPLETED ·Phase: NA
-
Effect of Long-term Oxygen Therapy on Exercise Capacity and Quality of Life in Patients With Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension
NCT01884012 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study of Inhaled GB002 for Treatment of WHO Group I Pulmonary Arterial Hypertension
NCT03926793 ·Status: COMPLETED ·Phase: PHASE1
-
Carbon Monoxide Therapy for Severe Pulmonary Arterial Hypertension
NCT01523548 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Acute Exposure to High Altitude on Heart Rate and Ventilation During Exercise
NCT03593096 ·Status: COMPLETED ·Phase: NA
-
A Study to Systematically Assess the Efficacy and Safety of Intravenous Albumin Infusions in Severe POTS
NCT03365414 ·Status: WITHDRAWN ·Phase: PHASE3
-
Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension
NCT01223352 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Follow-up Study of Inhaled Iloprost in Patients With Pulmonary Hypertension
NCT00185315 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Feasibility of Autologous Endothelial Progenitor Cells Transplantation in Patients With Idiopathic Pulmonary Arterial Hypertension
NCT00641836 ·Status: COMPLETED ·Phase: NA
-
Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension (PAH)
NCT00086463 ·Status: COMPLETED ·Phase: PHASE2
-
Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension
NCT03528902 ·Status: COMPLETED ·Phase: PHASE2